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Abstract 
Monoterpene production in Saccharomyces cerevisae requires the introduction of 
heterologous monoterpene synthases (MTSs). The endogenous farnesyl pyrosphosphate 
synthase (FPPS; Erg20p) competes with MTSs for the precursor geranyl pyrophosphate 
(GPP), which limits the production of monoterpenes. ERG20 is an essential gene that cannot 
be deleted and transcriptional down-regulation of ERG20 has failed to improve monoterpene 
production. Here, we investigated an N-degron-dependent protein degradation strategy to 
down-regulate Erg20p activity. Degron tagging decreased GFP protein half-life drastically to 
1 hour (degron K3K15) or 15 minutes (degrons KN113 and KN119). Degron tagging of 
ERG20 was therefore paired with a sterol responsive promoter to ensure sufficient metabolic 
flux to essential downstream sterols despite the severe destabilisation effect of degron 
tagging. A dual monoterpene/sesquiterpene (linalool/nerolidol) synthase, AcNES1, was used 
as a reporter of intracellular GPP and FPP production. Transcription of the synthetic pathway 
was controlled by either constitutive or diauxie-inducible promoters. A combination of 
degron K3K15 and the ERG1 promoter increased linalool titre by 27-fold to 11 mg L
-1
 in the 
strain with constitutive promoter constructs, and by 17-fold to 18 mg L
-1
 in the strain with 
diauxie-inducible promoter constructs. The sesquiterpene nerolidol remained the major 
product in both strains. The same strategies were applied to construct a limonene-producing 
strain, which produced 76 mg L
-1
 in batch cultivation. The FPPS regulation method developed 
here successfully redirected metabolic flux toward monoterpene production. Examination of 
growth defects in various strains suggested that the intracellular FPP concentration had a 
significant effect on growth rate. Further strategies are required to balance intracellular 
production of FPP and GPP so as to maximise monoterpene production without impacting on 
cellular growth. 
 
 
Keywords: metabolic engineering, synthetic biology, flux competition/redirection, protein 
destabilization, prenyl pyrosphosphate synthase, monoterpene 
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1. Introduction 
Metabolic engineering aims to enhance the productivity and the yield of the target metabolite 
through engineering metabolic and regulatory networks (Stephanopoulos and Vallino, 1991). 
Elimination or reduction of flux-competing reactions is commonly required to redirect 
metabolic flux toward the product of interest (Nielsen, 2011; Sabri et al., 2013). Gene 
deletion is used to remove reactions from the network; however, deletion in anabolic 
pathways can generate a lethal or auxotrophic phenotype. Lethality is obviously unhelpful, 
and addition of medium components to supplement for auxotrophies is cost-prohibitive in 
many industrial scenarios.  
An alternative approach is down-regulation of the target reaction, commonly achieved at the 
transcriptional level. This has been well demonstrated for production of 15-carbon 
sesquiterpenes from the isoprenoid family of natural products in yeast (Saccharomyces 
cerevisiae). Isoprenoids are constructed from 5-, 10-, 15-carbon (etc.) precursors which are 
sequentially produced via condensation of the 5-carbon dimethylallyl pyrophosphase 
(DMAPP) and its isomer isopentenyl pyrophosphate (IPP; Figure 1) (Vickers et al., 2015a). 
Heterologous production of industrially useful isoprenoids in yeast suffers from competition 
by the native sterol pathway, which uses the 15-carbon precursor intermediate, farnesyl 
pyrophosphate (FPP). The flux-competing enzyme is squalene synthase (Erg9p), an 
endoplasmic reticulum-associated protein. Transcriptional down-regulation of ERG9 by 
chromosomal promoter replacement (using BTS1, HXT1, or CTR3 promoters) has been 
applied to decrease competition and redirect flux from sterols to heterologous sesquiterpenes 
(Paddon et al., 2013; Scalcinati et al., 2012; Xie et al., 2014). We recently demonstrated a 
protein degradation approach for successful down-regulation at this node using an 
endoplasmic reticulum associated protein degradation signal (Peng et al., 2017b), the first 
demonstration of engineered protein degradation for yeast metabolic engineering. 
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Figure 1. Metabolic pathways for the production of various terpenes. EfmvaS, Enterococcus faecalis 
hydroxymethylglutaryl-CoA (HMG-CoA) synthase; EfmvaE, E. faecalis acetoacetyl-CoA thiolase/HMG-CoA 
reductase; HMG2K6R, HMG-CoA reductase 2 K6R mutant; ERG12, mevalonate kinase; ERG8, phosphomevalonate 
kinase; MVD1, mevalonate pyrophosphate decarboxylase; IDI1, isopentenyl diphosphate:dimethylallyl 
diphosphate isomerase; ERG20, farnesyl pyrophosphate synthase; ERG20W, ERG20 N127W mutant, geranyl 
pyrophosphate synthase; ERG9, squalene synthase; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl 
pyrophosphate; GPP, geranyl pyrophosphate; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; 
MTS, monoterpene synthase; STS, sesquiterpene synthase.  
 
There is significant interest in the industrial production of monoterpenes (10-carbon 
terpenoids) using yeast. Monoterpenes have attractive floral scents and useful biological 
activities (Zebec et al., 2016). They can also provide the light fraction for alternative kerosene 
jet-fuels (Brennan et al., 2012; Vickers et al., 2014). Monoterpenes are synthesized from the 
10-carbon precursor geranyl pyrophosphate (GPP). However, in S. cerevisiae, GPP and FPP 
are synthesized by a bi-functional enzyme, farnesyl pyrophosphate synthase (FPPS; Erg20p), 
which converts DMAPP and IPP into GPP and adds another IPP to produce FPP (Figure 1) 
(Anderson et al., 1989; Parks et al., 1995). GPP is not normally released by FPPS and this 
limits GPP availability for monoterpene production.  
Previously, enzymes from the mevalonate (MVA) pathway were over-expressed to increase 
precursor flux for terpene synthesis (Figure 1) (Peng et al., 2017a; Peng et al., 2017b; Vickers 
et al., 2017). A dedicated GPP synthase has been used to increase the GPP pool for 
monoterpene production (Alonso-Gutierrez et al., 2013; Amiri et al., 2016; Cao et al., 2016; 
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Liu et al., 2016; Rico et al., 2010; Sarria et al., 2014; Willrodt et al., 2014; Zhang et al., 
2014). However, yields were low compared to production of sesquiterpenes in a similar 
system, suggesting that the native Erg20p competes effectively with the monoterpene 
synthase for GPP. ERG20 is essential for anabolic metabolism of downstream essential 
cellular components including sterols, ubiquinone, and protein prenylation (Casey, 1992; 
Dickinson and Schweizer, 2004; Paltauf et al., 1992); deletion of ERG20 is lethal (Anderson 
et al., 1989; Giaever et al., 2002). Down-regulation strategies have therefore been applied. 
Deletion of one allele in a diploid strain (ERG20/erg20) improved sabinene production 
compared to a haploid (ERG20) strain (Ignea et al., 2013). However, the transcriptional 
down-regulation approach that was successfully applied to ERG9 for C15 production was 
unsuccessful when applied to down-regulate ERG20 for monoterpene geraniol production 
(Zhao et al., 2016; Zhao et al., 2017). It appears that classical promoter-mediated 
transcriptional level control is ineffective for metabolic engineering at the Erg20p node. 
In S. cerevisiae, ergosterol synthetic (ERG) enzymes are regulated both transcriptionally and 
through protein turnover mechanisms (Christiano et al., 2014). At the transcriptional level, 
ERG genes are regulated by sterol regulatory transcription factors including Upc2p (Vik and 
Rine, 2001; Yang et al., 2015). When ergosterol levels are high, ergosterol binds to the Upc2p 
carboxyl-terminal domain, preventing activity; when ergosterol is low, Upc2p is unbound and 
activates ERG gene transcription (Yang et al., 2015). This mechanism provides the basis for 
an exploitable feedback-control circuit that responds by increasing transcription in conditions 
of insufficient ergosterol. At the protein level, endoplasmic-reticulum-associated protein 
degradation (ERAD) modulates protein turnover of ER-associated ERG enzymes (Christiano 
et al., 2014; Foresti et al., 2013). Squalene epoxidase (ERG1) illustrates this multi-level 
regulation: ERG1 is upregulated by Upc2p in response to low ergosterol (Servouse and Karst, 
1986; Vik and Rine, 2001), while Erg1p is degraded through the ERAD pathway resulting in 
a short protein half-life (Foresti et al., 2013). We have previously exploited the ERAD 
mechanism to regulate Erg9p, resulting in flux redirection from squalene accumulation to 
sesquiterpene production (Peng et al., 2017b). In the current study, we aimed to improve 
monoterpene production by elevating the GPP pool. To achieve this, we developed an 
alternative protein degradation mechanism to downregulate the cytoplasmic FPP synthase and 
coupled it with an ergosterol responsive transcription modulator circuit, with the aim of 
producing high titres of monoterpenes while ensuring sufficient flux to sterols and avoid 
growth defects.  
 
2. Materials and Methods 
2.1 Plasmid and strain construction 
Plasmids used in this work are listed in Table 1 and strains are listed in Table 2. Primers used 
in polymerase chain reaction (PCR) and PCR performed in this work are listed in Appendix 
1: Table S1. Plasmid construction processes are listed in Appendix 1: Table S2.  
The SwaI-digested plasmids pILGF6, pILGF7 and pILGF8 were transformed separately into 
CEN.PK113-5D to generate GF6, GF7 and GF8.  
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Table 1. Plasmids used in this work 
Symbol > or < indicates the direction of open reading frame.  
 
 
Plasmid Features Addgene# Reference 
pILGFPE9 pILGFP3: PTEF1-yEGFP 83545 (Peng et al., 
2015) 
pILGFPF6 pILGFP3: PTEF1-UBI4-Degron(F:K3K15)-yEGFP - This work 
pILGFPF7 pILGFP3: PTEF1-UBI4-Degron(F:KN119)-yEGFP - This work 
pILGFPF8 pILGFP3: PTEF1-UBI4-Degron(F:KN113)-yEGFP - This work 
pRS423 E.coli/S. cerevisiae shuttle plasmid; 2μ, HIS3 - (Christianson 
et al., 1992) 
pRS424 E.coli/S. cerevisiae shuttle plasmid; 2μ, TRP1 - (Christianson 
et al., 1992) 
pRS425 E.coli/S. cerevisiae shuttle plasmid; 2μ, LEU2 - (Christianson 
et al., 1992) 
pPMVAu8 pRS423: PRPL4A>EfmvaS>TEFM1-PRPL15A>EfmvaE >TEBS1 98297 (Peng et al., 
2017b) 
pPMVAd3 pRS424: PRPL8B>ERG12>TNAT5-PSSB1>ERG8>TIDP1-
PRPL3>MVD1>TPRM9-PYEF3>IDI1>TRPL15A 
98298 (Peng et al., 
2017b) 
pPMVAd40R pRS424: ERG9
C-terminal
-TURA3- PGAL7>MVD1>TPRM9-PGAL2>-
ERG12>TNAT5-TIDP1<ERG8<PGAL10-PGAL1-IDI1-TRPL15A-
loxP-ble-loxP-TERG9 
98309 This work 
pPMVAd41 pRS424: ERG9
C-terminal
-CLN2
PEST
-TURA3- 
PGAL7>MVD1>TPRM9-PGAL2>-ERG12>TNAT5-
TIDP1<ERG8<PGAL10-PGAL1-IDI1-TRPL15A-loxP-ble-loxP-
TERG9 
98310 This work 
pJT1 pRS425: PTEF2-ERG20-TRPL3-PTEF1-AcNES1-TRPL41B 98299 (Peng et al., 
2017b) 
pJT2 pRS425: PTEF2>ScERG20
N127W
>TRPL3–
PTEF1>AcNES1>TRPL41B 
98306 This work 
pJT9R pRS425: TRPL3<ScERG20<PGAL1-PGAL2>AcNES1>TRPL41B 98305 (Peng et al., 
2017a) 
pJT10R pRS425: TRPL3<ScERG20
 N127W
<PGAL1-
PGAL2>AcNES1>TRPL41B 
98307 This work 
pJT11 pRS425: TRPL3<ScERG20
 N127W
<PGAL1-
PGAL2>ClLIS1>TRPL41B 
98308 This work 
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Table 2. S. cerevisiae strains used in this work 
Strain Genotype Resource/ 
reference 
Saccharomyces cerevisiae 
CEN.PK2-1C MATa ura3-52 trp1-289 leu2-3,112 his3Δ 1 (Entian 
and Kötter, 
1998) 
CEN.PK113-5D MATa ura3-52 (Entian 
and Kötter, 
1998) 
CEN.PK113-7D MATa (Entian 
and Kötter, 
1998) 
ILHA series strains:   
GH4 oJ3 derivative; ura3(1, 704 )::KlURA3 (Peng et 
al., 2015) 
GE9S oJ3 derivative; ura3(1, 704 )::KlURA3-PTEF1-yEGFP (Peng et 
al., 2015) 
GF6 oJ3 derivative; ura3(1, 704 )::KlURA3-PTEF1-UBI4-
Degron(F:K3K15)-yEGFP 
This work 
GF7 oJ3 derivative; ura3(1, 704 )::KlURA3-PTEF1-UBI4-
Degron(F:K119S)-yEGFP 
This work 
GF8 oJ3 derivative; ura3(1, 704 )::KlURA3-PTEF1-UBI4-
Degron(F:K113S)-yEGFP 
This work 
oURA3 CEN.PK2-1C derivative; URA3 (Peng et 
al., 2017b) 
o69 CEN.PK2-1C derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-
PERG8[SRE]-UBI4-Degron(F:K3K15) 
This work 
oI4 CEN.PK2-1C derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-
PERG1-UBI4-Degron(F:K3K15) 
This work 
oP6 CEN.PK2-1C derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-
PERG2-UBI4-Degron(F:K3K15) 
This work 
oP8 CEN.PK2-1C derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-
PERG2-UBI4-Degron(F:KN113) 
This work 
Oref oURA3 derivative; [pRS423] [pRS424] [pRS425] (Peng et 
al., 2017b) 
N6 oURA3 derivative; [pPMVAu8] [pPMVAd3] [pJT1] (Peng et 
al., 2017b) 
L6 oURA3 derivative; [pPMVAu8] [pPMVAd3] [pJT2] This work 
L669 o69 derivative; [pPMVAu8] [pPMVAd3] [pJT2] This work 
L6I4 oI4 derivative; [pPMVAu8] [pPMVAd3] [pJT2] This work 
L6P6 oP6 derivative; [pPMVAu8] [pPMVAd3] [pJT2] This work 
L6P8 oP8 derivative; [pPMVAu8] [pPMVAd3] [pJT2] This work 
o391 CEN.PK2-1C derivative;  
HMG2
K6R
(-152,-1)::HIS3-TEFM1<EfmvaS<PGAL1-
PGAL10>ACS2>TACS2-PGAL2> EfmvaE >TEBS1-PGAL7   
(Peng et 
al., 2017a) 
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pdc5(-31,94)::PGAL2> ERG12>TNATPTEF2>ERG8>TIDP1-
TPRM9<MVD1<PADH2-TRPL15A<IDI1<PTEF1-TRP1 
o401R o391 derivative; ERG9(1333, 1335)::TURA3- PGAL7>MVD1>TPRM9-
PGAL2>-ERG12>TNATTIDP1<ERG8<PGAL10-PGAL1-IDI1-TRPL15A-loxP-
ble-loxP 
This work 
o401R0L o401R derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-PERG1 This work 
o401RI4 o410R derivative; ERG20(-304, 3)::loxP-KlURA3-loxP-PERG1-
UBI4-Degron(F:K3K15) 
This work 
N401RA o401R derivative; URA3 [pJT9R] gal80::loxP-kanMX4-loxP This work 
L401RA o401R derivative; URA3 [pJT10R] gal80::loxP-kanMX4-loxP This work 
L401RoLA o401R0L derivative; [pJT10R] gal80::loxP-kanMX4-loxP This work 
L401RI4A o401RI4 derivative; [pJT10R] gal80::loxP-kanMX4-loxP This work 
LIM1A o401R derivative; URA3 [pJT11] gal80::loxP-kanMX4-loxP This work 
LIMI4A o401RI4 derivative; [pJT11] gal80::loxP-kanMX4-loxP This work 
Symbol > or < indicates the direction of open reading frames.  
 
Terpene-producing strains were constructed from S. cerevisiae CEN.PK2-1C by transforming 
plasmid DNA or PCR fragments using the LiAc/PEG/ssDNA method (Gietz and Schiestl, 
2007). The URA3 genotype was generated by transforming the URA3 fragment amplified 
from CEN.PK112-7D genomic DNA. ERG20 was modified on the genome by transforming 
the PCR fragment RERG20-LoxP-KlURA3-LoxP-PERG8[SRE]-Degron-RERG20 (Appendix 1: Table 
S1: #26, 27, &28) or RERG20-LoxP-KlURA3-LoxP-PERG1-RERG20 (Appendix 1: Table S1: #30). 
Strain o401R was generated from strain o391 by transforming SwaI-digested pIMVAd40R. 
The gene gal80 was disrupted by transforming the loxP-KanMX4-loxP fragment (Appendix 
1: Table S1: #31) amplified from plasmid pUG6, and the yeast strains were selected on 
synthetic complete-glutamate-high-glucose (SCGHG) agar plates with 300 μg mL-1 G-418; 
the nutrient recipe of the SCGHG agar is as follows: 1.6 g L
-1
 uracil-drop-out amino acid 
mixture (Hanscho et al., 2012), 1.7 g L-1 yeast nitrogen base without ammonium sulfate, 1 g 
L
-1
 glutamate, 200 g L
-1
 glucose. For terpene-producing strains, at least 3 single clones were 
stored separately in 20% glycerol at -80 °C as replicates.  
2.2 GFP fluorescence and degradation assay  
GFP fluorescence was monitored during the early exponential phase (OD600 = 0.4 to 0.8) as 
described previously (Peng et al., 2017b; Peng et al., 2015). Briefly, cells were cultivated 
aerobically in 20 ml SM-glucose medium in a 100 ml flask and GFP fluorescence was 
analysed using a BD AccuriTM C6 flow cytometer (BD Biosciences, USA). GFP 
fluorescence level was expressed as the percentage relative to the background auto-
fluorescence from a GFP-negative reference strain GH4 (empty vector integration strain). For 
the GFP degradation assay, cycloheximide was added into the culture to a final concentration 
of 50 mg L
-1
. 
2.3 Two-phase flask cultivation 
Two-phase flask cultivation was performed as described previously (Peng et al., 2017a; Peng 
et al., 2017b; Vickers et al., 2015b). Synthetic minimal (SM) medium (containing 6.7 g L
-1
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yeast nitrogen base, YNB, Sigma-Aldrich #Y0626; pH 6.0) with 20 g L
-1
 glucose as the 
carbon source was used (SM-glucose). 100 mM 2-(N-morpholino) ethanesulfonic acid (MES, 
Sigma-Aldrich#M8250) was used to buffer medium pH. Strains were recovered from glycerol 
stocks by streaking on SM-glucose agar plates (or SGCHG plates for strains with 
heterologous genes controlled by GAL promoters) and pre-cultured in MES-buffered SM 
medium with 20 g L
-1
 glucose or 40 g L
-1
 glucose (for strains with heterologous genes 
controlled by GAL promoters) as carbon source to exponential phase (cell density OD600 
between 1 and 4). Two-phase flask cultivation was initiated by inoculating pre-cultured cells 
to OD600 = 0.2 in 25 ml MES-buffered SM-glucose medium; 2 ml dodecane was added to 
extract terpene products. Flask cultivation was performed at 30 C and 200 rpm. For all 
cultivations, about 3 ml culture was sampled before the end of exponential growth phase for 
OD measurement. For RNA extraction, 2 ml exponential-phase culture (OD600 = 1 to 1.5) or 1 
ml post-exponential-phase culture (OD600 = 10 to 12) was sampled and cells were collected 
and stored at -80 C. For analysis of squalene and ergosterol, the cells from the final cultures 
were washed twice with distilled water and aliquots were stored at -20 C. 
The linear regression coefficients of the ln OD600 versus time during the exponential growth 
phase were the maximum growth rates (μmax) (Sonderegger et al., 2004).  
2.4 Extraction of ergosterol and squalene 
Ergosterol and squalene were extracted using a methanolic pyrogallol saponification as 
described previously (Peng et al., 2017b). Cell pellets were resuspended in an alkaline 
methanol solution with internal standard solution and pyrogallol. Saponification was 
performed at 80 C. Lipids were extracted with hexane, desiccated, and resuspended in 
methanol:ethanol (1:1) pyrogallol solution for HPLC analysis.  
2.5 Metabolite analysis 
Ergosterol, squalene and pyrene were analysed through reverse-phase chromatography as 
described previously (Peng et al., 2017b). Analytes were eluted isocratically at 1 mL min
-1
 
with methanol at 35
 o
C. Analytes were monitored using a diode array detector (Agilent 
Technologies) at the following UV wavelengths: 200 nm (for squalene), 274 nm (for 
ergosterol) and 334 nm (for pyrene).  
For linalool and trans-nerolidol analysis, dodecane samples were diluted 40-fold using hexane 
spiked with a β-pinene internal standard. Diluted samples were analysed with gas 
chromatography-mass spectrometry as described previously (Peng et al., 2017b). Samples (3 
μL) were injected in split mode (ratio 1:30) at 250 C; analytes were separated on a 
FactorFour VF-5ms GC column (30m*0.25μm*0.25μm)+10m EZ-guard (Agilent 
Technologies, PN: CP9013) with 1 mL min
-1
 helium flow and the following oven temperature 
gradient program: 50 C for 2 min, +15 C min-1 to 200 C, 200 C for 3 min, +40 C min-1 to 
325 C, 325 C for 0 min. Analytes were ionized and fragmented using electron impact (EI) 
ionization source and detected by mass spectrometry using a mass selective detector.  
An HPLC method, modified from a previous study (Peng et al., 2017a), was used to analyse 
geraniol, linalool, trans,trans-farnesol, trans-nerolidol, geranylgeraniol, and geranyllinalool. 
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Dodecane samples from fermentations were diluted in a 40-fold volume of ethanol. These 
samples (20μl) were analysed using an Agilent 1200 HPLC system with a Zorbax Extend C18 
column (4.6 x 150 mm, 3.5 µm, Agilent PN: 763953-902) and a guard column 
(SecurityGuard Gemini C18, Phenomenex PN: AJO-7597). Analytes were eluted at 35 
o
C at 
0.9 ml min
-1
 using a mixture of solvent A (high purity water, 18.2 kΩ) and solvent B (45% 
acetonitrile, 45% methanol and 10% water), with a linear gradient of 90% solvent B from 0-
21 min, then 90-100% solvent B from 21-31 min, then 100% from 31-38 min, and finally 5% 
from 38.1-43 min. Analytes of interest were monitored using a diode array detector (Agilent 
DAD SL, G1315C) at 202 nm wavelength. Spectral scans were also performed on each of the 
compounds from 190-400 nm in steps of 2 nm to confirm their identity and purity.  
Analytical standards of geraniol (98% purity; Sigma-Aldrich #163333), linalool (97% purity; 
Sigma-Aldrich #L2602), trans,trans-farnesol (96% purity; Sigma-Aldrich #277541), trans-
nerolidol (93.7% purity; Sigma-Aldrich #04610590), limonene (Sigma-Aldrich #W263303), 
geranylgeraniol (85% purity; Sigma-Aldrich #G3278), and geranyllinalool (95% purity; 
Sigma-Aldrich #48809), were used to prepare the standard curve for quantification. 
2.6 Quantitation of mRNA level 
Total RNA was extracted using a TRIzol® Plus RNA Purification Kit (Ambion #12183555). 
After DNase treatment, 0.2 μg total RNA was used for first-strand cDNA synthesis in a 10 μl 
reaction using ProtoScript® II Reverse Transcriptase (NEB #M0368). The diluted cDNA was 
used as the template for quantitative real-time (qRT) PCR (primers are listed in Appendix 1: 
Table S1 #33-to-#36).  KAPA SYBR
®
 FAST qPCR Kit (Kapa Biosystems #KP-KK4601) 
and CFX96 Touch™ Real-Time PCR Detection System (BIO-RAD) were used in qRT-PCR. 
Ct values were analyzed using CFX Manager Software (Bio-Rad Laboratories, QLD 
Australia). The actin-encoding gene ACT1 was used as reference for normalization. Real-time 
PCR data was analyzed according to the 2
−ΔΔCt
 method (Livak and Schmittgen, 2001).  
 
3. Results 
The native FPP synthase (Erg20p) competes with heterologous monoterpene synthases for 
GPP (Figure 2a). Transcriptional down-regulation of Erg20p is ineffective to control carbon 
competition at this node. Here, we aimed to reduce Erg20p to a minimal level required to 
maintain sterol flux for normal cell growth, and to re-direct carbon into monoterpene 
production. The strategy was inspired by the multilevel control seen in ergosterol 
biosynthesis. ERG1 is regulated transcriptionally by the sterol-responsive Upc2p transcription 
factor, which binds at sterol regulatory elements (SREs); in addition, Erg1p is regulated by 
endoplasmic reticulum-associated protein degradation. Erg20p is a cytosolic protein, with a 
half-life of >10 hour (Christiano et al., 2014). Destabilization of a cytosolic protein can be 
engineered by attaching an N-terminal degron, a C-terminal degron, or a PEST sequence 
(protein destabilizing sequence, rich in Pro, Glu, Ser and Thr) (Jungbluth et al., 2010; Mateus 
and Avery, 2000; Taxis et al., 2009). Degron-mediated degradation can be tuned due to a 
range of available sequences with differing efficiency for protein destabilisation; degrons are 
also short sequences that are easily introduced at protein termini. 
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3.1 Testing the N-end rule by destabilising GFP using N-degrons 
To engineer a destabilized Erg20p, we applied the N-degron-mediated protein degradation 
mechanism, known as the N-end rule pathway (Bachmair et al., 1986; Suzuki and 
Varshavsky, 1999). A ubiquitin moiety, an N-end rule residue, and a lysine-asparagine spacer 
(together the ‘degron’) were sequentially fused to the N-terminus of a protein (Figure 2a), 
following a previously-developed model (Suzuki and Varshavsky, 1999). The resulting fusion 
protein is hydrolysed by ubiquitin C-terminal hydrolase and the N-end rule residue is 
exposed, leading to ubiquitination on the lysine-asparagine spacer and the further protein 
degradation through the proteasome (Figure 2a).  
 
   
Figure 2. Schematic representation of engineered regulation on farnesyl pyrophsophate synthase Erg20p (a) and N-
degron-dependent degradation of green fluorescent protein GFP (b & c) in yeast. (a) The mechanism for ERG20 
regulation, including N-degron-dependent protein degradation and Upc2p-dependent sterol responsive 
transcriptional regulation: DMAPP, dimethylallyl pyrophosphate; IPP, isopentenyl pyrophosphate; GPP, geranyl 
pyrophosphate; FPP, farnesol pyrophosphate; Erg20p, FPP synthase; Erg20pW, FPP synthase mutant N127W; 
UBI/Ubi, ubiquitin. (b) GFP fluorescence levels in the strains (GE9S, GF6, GF7, and GF8) expressing the 
reference yEGFP, or the yEGFP fused with N-degron K3K15, KN119 or KN113. (c) GFP degradation analysis 
after adding cycloheximide. Mean values ± standard deviations are shown (N = 3). 
 
Protein degradation using three different degrons was tested using yeast enhanced green 
fluorescent protein (yEGFP) as the reporter protein (Figure 2b & 2c). GFP fluorescence is 
easily detected using a flow cytometer for high throughput and can provide a rapid response 
read-out (Peng et al., 2015) and is usually a very stable protein (Figure 2c), making it ideal 
for the current application. The three degrons tested (K3K15, KN119 and KN113) have a Phe 
residue as the N-end rule residue and additional 14-residue lysine-asparagine spacer which 
attracts different levels of ubiquitination and thus result in differing protein degradation rates 
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(Suzuki and Varshavsky, 1999). N-degron-yEGFP tagging resulted in dramatically decreased 
GFP fluorescence compared to the un-tagged yEGFP control (Figure 2b). Consistent with a 
previous study using β-glucosidase as a reporter protein (Suzuki and Varshavsky, 1999), the 
K3K15 degron was the least effective at decreasing fluorescence. No significant difference 
was observed in fluorescence levels between the KN119 and KN113 degron constructs (two-
tailed t-test p > 0.5). GFP protein turnover was tested by monitoring the fluorescence change 
after cycloheximide was added to stop protein translation (Figure 2c). The yEGFP:K3K15 
construct exhibited a protein half-life of 1 hour, and the yEGFP:KN119 and yEGFP:KN113 
constructs exhibited protein half-lives of ~ 15 min. Due to These data confirm that N-degron 
fusions can be used to destabilize a cytosolic protein and parameterised the degrons tested 
under our conditions.  
3.2 Engineering flux balance demand control at ERG20 for improved 
monoterpene production 
The dramatic destabilisation observed in degron-tagged GFP is unlikely to be useful as a flux 
modulation approach at the FPP synthase node because the resulting protein levels are likely 
to be too low to sustain sufficient flux to sterols, which are required for cell wall production 
and normal growth. However, as noted, previous attempts to engineer transcriptional down-
regulation of Erg20p for increased monoterpene production by replacing the native promoter 
with down-regulatable promoters were unsuccessful (Zhao et al., 2016; Zhao et al., 2017). To 
balance the severe effect of the degron-mediated degradation, we applied a feedback-
regulation mechanism by exploiting sterol responsive transcription elements to increase 
transcription under decreased ergosterol conditions. This was combined with the protein 
degradation approach with the aim of achieving a balance between maintenance of cell 
growth and minimising Erg20p activity, and thereby obtaining flux-demand control over this 
node (Figure 2a). 
The ERG20 promoter does not respond to ergosterol concentration, whereas ERG2, ERG1, 
and ERG8 do (Dimster-Denk et al., 1999; Kuranda et al., 2010; Vik and Rine, 2001). 
Transcript analysis under normal conditions demonstrates a relative transcript abundance of: 
ERG2 >> ERG20  ERG1 >> ERG8 (Christiano et al., 2014); 
in low ergosterol conditions, transcription from ergosterol-responsive promoters is up-
regulated ~ 10-fold (Dimster-Denk and Rine, 1996; Vik and Rine, 2001). The genomic 
ERG20 gene was modified by fusing an N-degron to the Erg20p N-terminus and replacing the 
promoter with a sterol responsive promoter. We tested the ERG8 promoter (PERG8), the ERG8 
promoter with additional SRE sequence inserted (PERG8[SRE]), the ERG1 promoter (PERG1), and 
the ERG2 promoter (PERG2); in combination with degrons K3K15, KN119, and KN113 (see 
above; Figure 2), making a total of 12 target promoter:degron combinations. Yeast 
transformants were successfully isolated for five combinations: PERG8[SRE]-K3K15, PERG1-
K3K15, PERG2-K3K15, PERG2-KN119, and PERG2-KN113. We presume that the other 
combinations were lethal, perhaps due to insufficient sterol production. In support of this, we 
observed that the weakest degron (K3K15) combined with all of the promoters except for the 
weakest promoter (PERG8) successfully yielded transformants; and that the strongest promoter 
(PERG2) worked with all of the degrons. Addition of an extra SRE was required to successfully 
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retrieve transformants for the ERG8 promoter (PERG8[SRE]). For those combinations that were 
successful, we noted that positive transformants formed smaller colonies on the selective 
plates than false-positive transformants (data not shown). 
In order to investigate the effect of these modifications on monoterpene production, three 
plasmids were introduced into the ERG20 control strain (CEN.PK2-1 derivative oURA3; 
Table 2) and the ERG20-modified strains (promoter replacement and degron tagged) 
described above (Table 2). Mevalonate pathway flux to the C5 isoprenoid precursors IPP and 
DMAPP was increased by introducing two plasmids expressing upper and lower MVA 
pathway modules (pPMVAu8 and pPMVAd3, respectively; Table 1 and Figure 1) which we 
have previously used to improve sesquiterpene titres (Peng et al., 2017b). The terpene 
synthetic pathway plasmid pJT2 was used as a flux reporter. pJT2 contains two genes: (a) a 
mutant Erg20p
N127W
 (Erg20p
W
, encoded by ERG20
W
) engineered to exclude FPP from its 
active site and thus release the GPP moiety, which accumulates GPP as the product (Ignea et 
al., 2013), and (b) a trans-nerolidol synthase (AcNES1) from Actinidia chinensis, which has 
both sesquiterpene synthase activity (producing nerolidol from FPP) and monoterpene 
synthase activity (producing linalool from GPP) (Green et al., 2012). AcNES1 can therefore 
act as a reporter for both GPP and FPP availability. These modifications resulted in strains 
with either non-modified or promoter/degron-modified ERG20, as well as an up-regulated 
mevalonate pathway and a monoterpene/sesquiterpene reporter system (Table 2). 
Previously, we used a similar set of plasmids with a native ERG20 (PERG20-ERG20) instead of 
the mutant Erg20p
W
 in the reporter plasmid to engineer increased FPP for sesquiterpene 
production. The resulting strain N6 produced 56 mg L
-1
 of the sesquiterpene nerolidol and 
farnesol production was below the detection limit (Peng et al., 2017b). We examined strain 
N6 for linalool production and it was not detected (Figure 3a), confirming that in this strain, 
GPP is not generally available for conversion into monoterpenes. Replacing ERG20 with 
ERG20
W
 in the terpene synthetic module resulted in a slight but not significant decrease in 
nerolidol (two tailed t-test p > 0.1), and production of 0.4 mg L
-1
 monoterpene linalool in the 
new strain L6 (Figure 3a). Strain N6 grows at about half the rate of the control strain without 
engineering (µmax of ~0.15 compared to 0.3 h
-1
; (Peng et al., 2017b)). Interestingly, strain L6 
showed faster growth (µmax of ~0.2 h
-1
) than strain N6 (Figure 3b & 3d). 
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Figure 3. Characterisation of the strains overexpressing the mevalonate pathway and nerolidol/linalool synthetic 
module [ERG20(W)+AcNES1] using constitutive promoters and with/without the genomic ERG20 modified. (a) 
Linalool titres at 72 hour. (b) Growth curves over the batch cultivation. (c) nerolidol titres at 72 hour. (d) 
Maximum specific growth rates (μmax) during the exponential phase. (e) Intracellular squalene contents. (f) 
Intracellular ergosterol contents. Dash lines in e & f show the squalene and ergosterol levels in the reference strain 
Oref without mevalonate pathway enhanced. Mean values ± standard deviations are shown (N = 3). Data for 
strains N6 and Oref was published in our previous study (Peng et al., 2017b). Linalool and nerolidol were analyzed 
using GC-MS. For a, c &d, two-tailed Welch's t-test was used for statistical analysis relative to L6: n, p > 0.1; m, p 
∈ [0.05, 0.1]; s, p < 0.05. For e & f, two-tailed Welch's t-test was used for statistical analysis of log-transformed 
data (n’ and s’) or original data (n, m, and s) relative to Oref:  n’/n, p > 0.1; m’, p ∈ [0.05, 0.1]; s’/s, p < 0.05. 
 
0
5
10
15
L
in
a
lo
o
l 
(m
g
 L
-1
)
0
5
10
15
20
25
0 10 20 30 40 50 60 70 80
O
D
6
0
0
Time (hour)
N6
L6
L669
L6I4
L6P6
L6P8
a b
c
d
s
s
s
s
0
25
50
75
N
e
ro
li
d
o
l
(m
g
 L
-1
)
s
n
n
m
m
0
0.05
0.1
0.15
0.2
0.25
0.3
μ
m
a
x
 (
/h
o
u
r)
s
m
s
s s
B
e
lo
w
 
d
e
te
c
ti
o
n
e f
0
2
4
6
8
10
12
14
N6 L6 L669 L6I4 L6P6 L6P8
s’ s’
s’
s’
s’ s’
0
2
4
6
8
10
12
14
N6 L6 L669 L6I4 L6P6 L6P8
n
n n
m
nm
S
q
u
a
le
n
e
 (
m
g
 g
 -
1
 b
io
m
a
s
s
)
E
rg
o
s
te
ro
l
(m
g
 g
 -
1
 b
io
m
a
s
s
)
15 
 
The same three plasmids (upper and lower MVA modules; and ERG20
W
+AcNES1) were 
introduced into the strains with the genomic ERG20-modifications to generate strain L669 
(PERG8[SRE]-K3K15-ERG20), L6I4 (PERG1-K3K15-ERG20), L6P6 (PERG2-K3K15-ERG20), and 
L6P8 (PERG2-KN113-ERG20) (Figure 3). All of these strains exhibited increased linalool 
production compared to strain L6 (two-tailed t-test p < 0.05; Figure 3a). The highest average 
linalool titres achieved were ~11 mg L
-1
 in the PERG1-K3K15-ERG20 and PERG2-KN113-
ERG20 strains. Growth and nerolidol titres in these strains were variable (Figure 3b, 3c & 
3d). The PERG8[SRE]-K3K15-ERG20 strain showed dramatically impaired growth and reduced 
nerolidol titre, as well as having the lowest linalool titre of the chromosomally engineered 
strains. The other strains (PERG1-K3K15-ERG20, PERG2-K3K15-ERG20 and PERG2-KN113-
ERG20) still produced > 25 mg L
-1
 nerolidol; maximum growth rates in these strains were 
similar to strain N6, but lower than strain L6 (Figure 3). These data demonstrate that the 
ERG20 modifications examined increased monoterpene production but did not eliminate 
sesquiterpene production. Moreover, growth rates were still negatively impacted. They also 
demonstrate that different promoter/degron combinations resulted in different carbon balance 
between the C10 and C15 products. 
3.3 Squalene and ergosterol content in ERG20-modified strains 
In our previous study, overexpressing the MVA modules resulted in squalene accumulation in 
the sesquiterpene strain N6 compared to the wild-type strain Oref (dashed line in Figure 4e), 
indicating excess FPP was converted to squalene instead of sesquiterpene (Peng et al., 
2017b). Strain L6 exhibited a similarly increased squalene content (Figure 3e), suggesting in 
the presence of upstream pathway engineering, excess FPP is produced and converted to 
squalene (as well as sesquiterpene). Likewise, all of the genomic ERG20-modified strains 
(L669, L6I4, L6P6 and L6P8) had increased squalene content relative to the control strain. 
These data indicate that excess carbon is overflowing into squalene production in all of the 
strains. However, in the case of strain L669, (PERG8[SRE]-K3K15-ERG20; the weakest promoter 
combined with the weakest degron), squalene accumulation was about half that compared to 
N6 and L6 (log-transformed data; one-tailed t-test p < 0.05). As noted above, the growth rate 
in this strain was also very low (Figure 3b & 3d); there is no apparent reason for this 
considering that sufficient squalene and ergosterol is available (Figure 3e & 3f). Ergosterol 
content in the ERG20-modified strains was not significantly different to the control strain 
Oref (dashed line in Figure 4f) and strain L6 (Figure 3f). 
 
3.4 Engineering ERG20 for improved monoterpene production in high-level 
sesquiterpene-producing background strain 
The promoters used to drivheterologous genes in the above constructs have decreased 
expression activities in the post-exponential phase (Peng et al., 2015), resulting in decreased 
productivities (Peng et al., 2017a). We have previously shown that sesquiterpene productivity 
can be improved by using diauxie-inducible GAL promoters in a gal80Δ background strain 
instead of constitutive promoters (Peng et al., 2017a). When GAL promoters were used, the 
resulting strain N391DA produced 400 mg L
-1
 nerolidol in flask cultivations (Peng et al., 
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2017a). In this strain, we observed mevalonate accumulation (unpublished data), suggesting 
that the lower MVA pathway is a flux bottleneck. This is probably due to the upstream 
module being controlled by GAL promoters while the downstream module was still controlled 
by constitutive promoters. We therefore first constructed a new background strain from the 
N391DA parent strain o391 (Table 1) by introducing a copy of the lower-part MVA pathway 
module controlled by GAL promoters (the pIMVAd40R plasmid, producing strain o401R; 
Table 2). The gal80 disruption and a PGAL-controlled ERG20+AcNES1 module (pJT9R; 
Table 1) were introduced to generate a terpene production strain (strain N401RA; Table 2). 
This strain N401RA has all heterologous genes (upper and lower MVA pathway and 
ERG20+AcNES1 terpene production module) controlled by GAL promoters. Similar to strain 
N391DA from our previous study, strain N401RA produced ~ 400 mg L
-1
 nerolidol at 72 h 
(Figure 4d). It also produced ~20 mg L
-1
 of the C15 isoprenoid alcohol farnesol and ~15 mg 
L
-1
 of the C20 isoprenoid alcohol geranylgeraniol (Figure 4c & 4e), which are commonly 
produced by endogenous non-specific hydroxylation in the presence of excess FPP/GGPP 
(Farhi et al., 2011; Peng et al., 2017b). This suggests that excess prenyl phosphate was 
dephosphorylated instead of being converted into nerolidol. No monoterpenes (linalool and 
geraniol) were detected, as expected considering the absence of dedicated GPPS activity in 
this strain; and growth rate was unaffected (Figure 4f).  
Swapping the ERG20 gene with the GPP-producing ERG20
W
 mutant (pJT10R, to make strain 
L401RA; Table 2) resulted in production of small amounts of the monoterpenes linalool 
(~1.0 mg L
-1
) and geraniol (the hydrolysis product of GPP; ~0.15 mg L
-1
) (Figure 4a & 4b). 
Neither growth nor production of sesquiterpene and diterpene products (farnesol, nerolidol, 
and geranylgeraniol) were significantly different in this strain (Figure 4c-4f).  
The genomic ERG20 gene was further engineered by replacing the promoter with the sterol-
regulative promoter, PERG1 (similar transcriptional strength to the ERG20 promoter; no 
degron; strain L401RoLA) or with PERG1:K3K15 degron (weakest degron; strain L401RI4A). 
Strain L401RoLA exhibited very slight increase in monoterpene production (linaool, ~1.7 mg 
L
-1
 and geraniol, ~0.22 mg L
-1
) compared to strain L401RA (Figure 4a & 4b), but no 
significant change in sesquiterpene and diterpene production (Figure 4c-4e). A decreased 
maximum growth rate (0.18 h
-1
) relative to N401RA and L401RA was also observed (Figure 
4f).  
A remarkable increase in monoterpene production (~18 mg L
-1
 linalool and ~16 mg L
-1
 
geraniol, >18-fold more than the reference L401RA) was observed in strain L401RI4A 
(Figure 4a & 4b), accompanied by a significant decrease in sesquiterpene (nerolidol and 
farnesol) and diterpene (geranylgeraniol) production (Figure 4c-4e). This strain also 
exhibited a sharp decrease in growth rate, to ~0.09 h
-1
 (Figure 4f & 4g).  
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Figure 4. Characterisation of the strains overexpressing the mevalonate pathway and nerolidol/linalool synthetic 
genes [ERG20(W)+AcNES1] using diauxie-inducible promoters and with/without modifying the genomic ERG20. 
(a) Linalool titres, (b) geraniol titres, (c) farnesol titres, (d) nerolidol titres, and (e) geranylgeraniol titres at 72 
hour. (f) Maximum specific growth rates (μmax) during the exponential phase. (g) Growth curves over batch 
cultivation. Terpenes were analyzed using the LC-UV method. Mean values ± standard deviations are shown (N = 
3). Two-tailed Welch's t-test was used for statistical analysis relative to L401RA: n, p > 0.1; m, p ∈ [0.05, 0.1]; s, 
p < 0.05.  
 
3.5 Transcriptional response of sterol-responsive genes in genomic ERG20-
modified strains 
To examine transcriptional responses to ERG20 promoter modification, we performed 
quantitative real-time PCR using strains N401RA (overexpressed ERG20, no genomic ERG20 
modification), L401RA (ERG20
W
, no genomic ERG20 modification), L401RoLA (ERG20
W
, 
PERG20 replaced with PERG1), and L401RI4A (ERG20
W
, PERG20 replaced with PERG1; K3K15 
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degron). Expression of the genomic ERG20 and the overexpressed ERG20 or ERG20
W
 cannot 
be differentiated using this approach, so there should be no difference between strains 
N401RA and L401RA (control experiment). However, if a sterol response is present, it 
should be observable in the other sterol-responsive genes, including squalene epoxidase 
(ERG1) and C-8 sterol isomerase (ERG2). mRNA levels for these genes were examined 
(Figure 5). ACT1 was used as the reference gene for normalization. PDA1 was used as a 
second reference gene for method validation. Strain data was normalized to N401RA (i.e. the 
other strain data is presented as fold-change relative to N401RA). In both exponential and 
ethanol growth phases, PDA1 transcript level was not significantly different between 
N401RA and the other three strains, confirming that the ACT1 normalization was appropriate 
across cultivation phases. ERG1 and ERG2 mRNA levels were also similar between N401RA 
and L401RA in both fermentation stages. In the exponential phase, ERG1 and ERG2 
transcript levels were lower (significant only for ERG2) in genomic ERG20-modified strains 
L401RoLA and L401RI4A relative to the ERG20 unmodified strains; whereas in the ethanol 
growth phase, ERG1 and ERG2 transcription was higher. This suggests that, if a response was 
present, it occurred in the ethanol phase but not in the exponential phase. 
  
Figure 5. Analysis of mRNA levels in the exponential growth phase (a) and the ethanol growth phase (b). Data 
were normalized using the reference ACT1 data in the exponential or ethanol growth phase, separately. Mean 
values ± standard deviations are shown (N = 3). Two-tailed Welch's t-test was used for statistical analysis relative 
to N401R: n, p > 0.1; m, p ∈ [0.05, 0.1]; s, p < 0.05. 
 
3.6 Producing limonene in ERG20-engineered strain 
Limonene is an interesting monoterpene product that can be used as fragrance, organic 
solvent, chemical precursor, and a component of renewable aviation fuels (Brennan et al., 
2012). Here, limonene production was evaluated using two of the intensively engineered 
background strains described above. The limonene synthesis plasmid included ERG20
W
 and 
Citrus limon limonene synthase (ClLS; (Behrendorff et al., 2013)), both under the control of 
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GAL promoters (pJT11; Table 2). Strains LIM1A (native genomic ERG20) and LIMI4A 
(PERG1-K3K15:ERG20) were generated by transforming this plasmid into strains o401R and 
o401RI4 (Table 1), which have a GAL promoter-controlled overexpressed MVA pathway.  
 
Figure 6. Characterisation of the strains overexpressing mevalonate pathway and limonene synthetic gene 
(ERG20W+ClLIS1) using diauxie-inducible promoters. (a) Strain LIM1A (without engineering on genomic 
ERG20). (b) Strain LIMI4A (with genomic ERG20 modified into PERG1-K3K15-ERG20). Mean values ± standard 
deviations are shown (N = 2). 
 
Similar to the nerolidol/linalool-producing strains (L401RA and L401RI4A; Figure 4), the 
genomic modification of ERG20 lead to decreased exponential growth rate in strain LIMI4A 
(μmax = 0.10 h-1), compared to strain LIM1A (μmax = 0.28 h-1; Figure 6). Strain LIM1A 
exhibited a different growth defect: cell division stopped after 24 hour (Figure 6a), whereas 
strain LIMI4A continued to grow in the post-exponential phase (Figure 6b). Although growth 
stopped in LIM1A, farnesol and geranylgeraniol accumulation increased in the post-
exponential phase (Figure 6a), showing that the post-exponential cells are still metabolically 
active despite not undergoing cell division. Monoterpene production (limonene and geraniol) 
was below detection in LIM1A (Figure 6a). In contrast, monoterpenes limonene and 
geraniol, as well as farnesol and geranylgeraniol, were produced in genomic ERG20-
engineered strain LIMI4A (Figure 6b). Geraniol titre was 27 mg L
-1
 at 96 hour, and limonene 
titre was ~76 mg L
-1
.  
 
4. Discussion 
While sesquiterpenes have been successfully produced at high g/L titres (Meadows et al., 
2016; Peng et al., 2017a), monoterpene production lags far behind. The best monoterpene 
titres have been achieved in E. coli (e.g. limonene was produced up to 400 mg L
-1
 from 10 g 
L
-1
 glucose in E. coli (Alonso-Gutierrez et al., 2013)), while production in yeast remains 
challenging. It is thought that the high level limonene production in E. coli might result from 
effective competition by the limonene synthase with the native E. coli FPP synthase (Willrodt 
et al., 2014), an unusual situation given the relatively poor kinetic properties of most terpene 
synthases. In yeast, it seems likely that the FPP synthase outcompetes the heterologous 
monoterpene synthases for GPP. A titre of 85 mg L
-1
 linalool was recorded in S. cerevisiae 
strain with enhanced MVA pathway flux, an erg9Δ mutation, chromosomal replacement of 
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the FPP synthase (Erg20p) with a GPP-accumulating mutant, and overexpressing an 
additional GPP-accumulating FPP synthase mutant and a strawberry (Fragaria × ananassa) 
nerolidol synthase from a plasmid (Zhuang, 2013). However, this strain showed a dramatic 
growth deficiency and required a 14-day cultivation (20 g L
-1
 glucose) to obtain this titre. In 
other engineered microbial strains, linalool production titres remain in the μg L-1 scale (Amiri 
et al., 2016; Rico et al., 2010). The highest titres for other monoterpenes in batch cultivation 
in engineered microorganisms are currently 41 mg L
-1
 for sabinene in E.coli (Zhang et al., 
2014), 32 mg L
-1
 for pinene in E.coli (Sarria et al., 2014), 66 mg L
-1
 for geraniol in S. 
cerevisiae (Zhao et al., 2016), 69 mg L
-1
 for geraniol in E.coli (Liu et al., 2016), and 24 mg L
-
1
 for limonene in Yarrowia lipolytica (Cao et al., 2016). 
In this study, we first improved upstream pathway flux to increase the availability of prenyl 
phosphates, then engineered at the flux-competing enzyme, FPPS. Transcriptional regulation 
has previously been shown to be inadequate to control flux competition at FPPS (Zhao et al., 
2016; Zhao et al., 2017). FPPS is a very stable protein (Christiano et al., 2014), and this may 
help mitigate down-regulation through transcriptional regulation. We instead applied 
regulation at the protein level through the N-end-rule protein degradation mechanism. We 
also implemented an ergosterol-responsive transcriptional up-regulation mechanism designed 
to engage if the cellular ergosterol levels became too low (which might cause a growth 
defect). This regulatory engineering increased monoterpene production in strains with either 
constitutively overexpressed monoterpene synthetic pathways or inductively overexpressed 
monoterpene synthetic pathways. The highest titres achieved here were 18 mg L
-1
 for linalool 
and 76 mg L
-1
 limonene. This is the highest currently-reported titre for limonene in yeast. 
Although leading to improved monoterpene production, the current strategy did not eliminate 
the accumulation of sesquiterpenes, diterpenes, and squalene (Figures 3, 4, & 6). In our 
previous study, down-regulating the native squalene synthase by protein destabilization 
strongly re-directed carbon from the sterol pathway into sesquiterpene production (Peng et al., 
2017b). In contrast, down-regulation of the native ERG20 in the current study did not have a 
particularly strong effect on downstream metabolites (squalene, ergosterol, and 
sesquiterpenes), although it did increase monoterpene production, which was the aim. The 
ERG20
W
 mutant which was introduced to increase GPP availability still has FPP synthase 
activity (Ignea et al., 2013); this may have provided sufficient flux to maintain downstream 
intermediate pools despite the decrease in FPPS activity derived from the native chromosomal 
gene. 
The accumulation of terpene alcohols such as geraniol, farnesol, and geranylgeraniol, has 
been shown in previously studies (Farhi et al., 2011; Peng et al., 2017b; Zhao et al., 2016), 
and is likely coupled with increased intracellular concentrations of prenyl pyrophosphate 
precursors. Production of these terpene alcohols can be attributed to dephosphorylation of 
prenyl pyrophosphate precursors through enzymatic catalysis or non-enzymatic reactions, 
whereas potential enzymatic mechanisms include hydrolysis by endogeneous phosphatases 
such as Dpp1p and Lpp1p (Scalcinati et al., 2012; Tokuhiro et al., 2009) and solvolysis by 
prenyl transferases such as GPP synthase and FPP synthase (Poulter and Rilling, 1976; Saito 
and Rilling, 1979).  
We hypothesised that sterol-responsive transcriptional regulation through the Upc2p 
transcription factor might be activated in ERG20-modified strains to complement protein 
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degradation, resulting in a balance to maintain ergosterol concentration. To examine this more 
carefully, we looked at the transcriptional profile of ERG genes in engineered strains. Because 
of the plasmid-mediated expression of ERG20 or ERG20
W
, we could not specifically measure 
transcriptional change of the genomic ERG20; however, we looked at the sterol-responsive 
genes ERG1 and ERG2 in ERG20-modified strains. The transcription levels in both PERG2-
K3K15-ERG20 and PERG1-ERG20 strains (L401RI4A and L401RoLA) decreased (though not 
significantly) in the exponential phase, and increased by ~1-fold in the post-exponential phase 
(Figure 5). This suggests that the Upc2p-mediated sterol responsive regulation was activated, 
but only in the post-exponential phase; and not as dramatically as shown in previous studies 
where the enzymatic inhibitors were added to constrain sterol synthesis (Vik and Rine, 2001).  
In previous studies, the growth profiles of engineered monoterpene-producing yeast strains 
were not compared (Amiri et al., 2016; Liu et al., 2013; Zhang et al., 2014; Zhao et al., 2016). 
Here, we showed that the growth of engineered strains was strongly influenced by the 
different genetic engineering approaches. (1) Strain L6 (ERG20
W
 mutant overexpressed; µ = 
0.22 h
-1
) exhibited faster exponential growth rate than strain N6 (native ERG20 is 
overexpressed µ = 0.14 h
-1
; Figure 3). (2) Genetic modifications on genomic ERG20 
decreased the exponential growth rate, including the genotypes PERG8[SRE]-K3K15-ERG20 
(strain L669), PERG1-K3K15-ERG20 (strain L6I4 & L401RI4A), PERG2-K3K15-ERG20 (strain 
L6P6), PERG2-KN113-ERG20 (strain L6P8), and even the genotype PERG1-ERG20 (strain 
L401RoLA), which had no N-degron-dependent protein destabilization of Erg20p (Figure 3 
& Figure 4). (3) Cell growth for strain LIM1A (limonene production plasmid with native 
ERG20 overexpressed) halted in the post-exponential phase (Figure 6), suggesting severe 
metabolic imbalance. These results indicate that flux control at the Erg20p node is a critical 
determinant of cell growth. 
Product toxicity is probably not the cause of the observed growth defects, because linalool 
titres (Figure 3) were below toxic levels (Appendix 1: Figure S1) and in any case, addition 
of a dodecane extraction phase such as we used alleviates monoterpene toxicity (Brennan et 
al., 2012). Genomic ERG20-engineered strains still accumulated FPP-derivative products 
(squalene, nerolidol, and geranylgeraniol) at much higher levels than the control (Figure 3 & 
4), which suggests that the decreased growth rate was not caused by insufficient metabolic 
flux to FPP.  
In contrast to the nerolidol/linalool-producing strains having both GPP-and-FPP-sink 
pathways (via dual-activity nerolidol synthase), the limonene strains LIM1A and LIMI4A 
only harbor a heterologous GPP-sink pathway (via limonene synthase). Strain LIM1A 
showed a normal exponential growth, but growth halted in the post-exponential phase (Figure 
6a). In contrast, strain LIMI4A showed inhibited exponential growth (presumably due to the 
genomic ERG20 modification), and a normal post-exponential growth (Figure 6b). In these 
strains, enhancement of MVA pathway flux from overexpressed genes was regulated by 
diauxie-inducible promoters, which are strongly enhanced in the post-exponential phase but 
not the exponential phase (Peng et al., 2017a). Considering this, it is possible that growth 
arrest in LIM1A might be due to accumulation of intracellular FPP in the post-exponential 
phase. This is supported by production of farnesol in this phase (Figure 6a). The engineering 
on genomic ERG20 in LIMI4A partially re-directed the flux from FPP synthesis to the GPP 
sink (limonene) pathway (Figure 6b). This might alleviate the toxicity caused by FPP 
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accumulation. In support of this, strain LIMI4A produced less farnesol compared to strain 
LIM1A (Figure 6b vs. 6a).  
5. Conclusion 
N-degron-mediated protein degradation and sterol-responsive transcriptional regulation were 
engineered to regulate genomic FPP synthase Erg20p, with the aim of redirecting carbon flux 
toward monoterpene synthesis. This regulatory strategy increased monoterpene production in 
the strains, in which heterologous monoterpene synthetic pathway genes were overexpressed 
under the control of either constitutive promoters or diauxie-inducible promoters. Titres of 18 
mg L
-1
 linalool or 76 mg L
-1
 limonene were reached in engineered strains using 20 g L
-1
 
glucose. However, we found that engineered strains still produced considerable amounts of 
non-targeted products, geraniol, farnesol and geranylgeraniol; and that engineering on the 
genomic Erg20p engineering inhibited exponential growth. We postulate that an imbalance in 
synthesis of prenyl pyrophosphate (possibly accumulation of FPP) might cause growth 
inhibitions. Future work will focus on investigating this hypothesis. In summary, this strategy 
can be applied with further novel and combinatorial engineering strategies for 
economic/efficient production of monoterpene in yeast.  
 
Acknowledgements 
BP was supported by a University of Queensland International Postgraduate Research 
Scholarship. CEV was supported by Queensland Government Smart Futures and Accelerate 
Fellowships. Metabolite analysis was performed in the Metabolomics Australia Queensland 
Node. We thank Dr Manuel R. Plan for HPLC analysis and Dr Panagiotis Chrysanthopoulos 
for GC analysis.  
 
References 
Alonso-Gutierrez, J., Chan, R., Batth, T. S., Adams, P. D., Keasling, J. D., Petzold, C. 
J., Lee, T. S., 2013. Metabolic engineering of Escherichia coli for limonene 
and perillyl alcohol production. Metabolic engineering. 19, 33-41. 
Amiri, P., Shahpiri, A., Asadollahi, M. A., Momenbeik, F., Partow, S., 2016. Metabolic 
engineering of Saccharomyces cerevisiae for linalool production. 
Biotechnology letters. 38, 503-8. 
Anderson, M. S., Yarger, J. G., Burck, C. L., Poulter, C. D., 1989. Farnesyl 
diphosphate synthetase. Molecular cloning, sequence, and expression of an 
essential gene from Saccharomyces cerevisiae. The Journal of biological 
chemistry. 264, 19176-84. 
Bachmair, A., Finley, D., Varshavsky, A., 1986. In vivo half-life of a protein is a 
function of its amino-terminal residue. Science. 234, 179-86. 
Behrendorff, J. B. Y. H., Vickers, C. E., Chrysanthopoulos, P., Nielsen, L. K., 2013. 
2,2-Diphenyl-1-picrylhydrazyl as a screening tool for recombinant 
monoterpene biosynthesis. Microb Cell Fact. 12, 76. 
Brennan, T. C., Turner, C. D., Kromer, J. O., Nielsen, L. K., 2012. Alleviating 
monoterpene toxicity using a two-phase extractive fermentation for the 
bioproduction of jet fuel mixtures in Saccharomyces cerevisiae. Biotechnology 
and bioengineering. 109, 2513-22. 
23 
 
Cao, X., Lv, Y. B., Chen, J., Imanaka, T., Wei, L. J., Hua, Q., 2016. Metabolic 
engineering of oleaginous yeast Yarrowia lipolytica for limonene 
overproduction. Biotechnology for biofuels. 9, 214. 
Casey, P. J., 1992. Biochemistry of protein prenylation. Journal of lipid research. 33, 
1731-40. 
Christiano, R., Nagaraj, N., Frohlich, F., Walther, T. C., 2014. Global proteome 
turnover analyses of the Yeasts S. cerevisiae and S. pombe. Cell reports. 9, 
1959-65. 
Christianson, T. W., Sikorski, R. S., Dante, M., Shero, J. H., Hieter, P., 1992. 
Multifunctional yeast high-copy-number shuttle vectors. Gene. 110, 119-22. 
Dickinson, J. R., Schweizer, M., 2004. Metabolism and molecular physiology of 
Saccharomyces cerevisiae. CRC press. 
Dimster-Denk, D., Rine, J., 1996. Transcriptional regulation of a sterol-biosynthetic 
enzyme by sterol levels in Saccharomyces cerevisiae. Molecular and cellular 
biology. 16, 3981-9. 
Dimster-Denk, D., Rine, J., Phillips, J., Scherer, S., Cundiff, P., DeBord, K., Gilliland, 
D., Hickman, S., Jarvis, A., Tong, L., Ashby, M., 1999. Comprehensive 
evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae 
utilizing the Genome Reporter Matrix. Journal of lipid research. 40, 850-60. 
Entian, K.-D., Kötter, P., 1998. 23 yeast mutant and plasmid collections. Methods in 
microbiology. 26, 431-449. 
Farhi, M., Marhevka, E., Masci, T., Marcos, E., Eyal, Y., Ovadis, M., Abeliovich, H., 
Vainstein, A., 2011. Harnessing yeast subcellular compartments for the 
production of plant terpenoids. Metabolic engineering. 13, 474-481. 
Foresti, O., Ruggiano, A., Hannibal-Bach, H. K., Ejsing, C. S., Carvalho, P., 2013. 
Sterol homeostasis requires regulated degradation of squalene 
monooxygenase by the ubiquitin ligase Doa10/Teb4. eLife. 2, e00953. 
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Veronneau, S., Dow, S., 
Lucau-Danila, A., Anderson, K., Andre, B., Arkin, A. P., Astromoff, A., El-
Bakkoury, M., Bangham, R., Benito, R., Brachat, S., Campanaro, S., Curtiss, 
M., Davis, K., Deutschbauer, A., Entian, K. D., Flaherty, P., Foury, F., 
Garfinkel, D. J., Gerstein, M., Gotte, D., Guldener, U., Hegemann, J. H., 
Hempel, S., Herman, Z., Jaramillo, D. F., Kelly, D. E., Kelly, S. L., Kotter, P., 
LaBonte, D., Lamb, D. C., Lan, N., Liang, H., Liao, H., Liu, L., Luo, C., Lussier, 
M., Mao, R., Menard, P., Ooi, S. L., Revuelta, J. L., Roberts, C. J., Rose, M., 
Ross-Macdonald, P., Scherens, B., Schimmack, G., Shafer, B., Shoemaker, 
D. D., Sookhai-Mahadeo, S., Storms, R. K., Strathern, J. N., Valle, G., Voet, 
M., Volckaert, G., Wang, C. Y., Ward, T. R., Wilhelmy, J., Winzeler, E. A., 
Yang, Y., Yen, G., Youngman, E., Yu, K., Bussey, H., Boeke, J. D., Snyder, 
M., Philippsen, P., Davis, R. W., Johnston, M., 2002. Functional profiling of 
the Saccharomyces cerevisiae genome. Nature. 418, 387-91. 
Gietz, R. D., Schiestl, R. H., 2007. High-efficiency yeast transformation using the 
LiAc/SS carrier DNA/PEG method. Nat. Protocols. 2, 31-34. 
Green, S. A., Chen, X., Nieuwenhuizen, N. J., Matich, A. J., Wang, M. Y., Bunn, B. J., 
Yauk, Y. K., Atkinson, R. G., 2012. Identification, functional characterization, 
and regulation of the enzyme responsible for floral (E)-nerolidol biosynthesis 
in kiwifruit (Actinidia chinensis). Journal of experimental botany. 63, 1951-
1967. 
Hanscho, M., Ruckerbauer, D. E., Chauhan, N., Hofbauer, H. F., Krahulec, S., 
Nidetzky, B., Kohlwein, S. D., Zanghellini, J., Natter, K., 2012. Nutritional 
requirements of the BY series of Saccharomyces cerevisiae strains for 
optimum growth. FEMS yeast research. 12, 796-808. 
24 
 
Ignea, C., Pontini, M., Maffei, M. E., Makris, A. M., Kampranis, S. C., 2013. 
Engineering Monoterpene Production in Yeast Using a Synthetic Dominant 
Negative Geranyl Diphosphate Synthase. ACS synthetic biology. 
Jungbluth, M., Renicke, C., Taxis, C., 2010. Targeted protein depletion in 
Saccharomyces cerevisiae by activation of a bidirectional degron. BMC 
systems biology. 4, 176. 
Kuranda, K., Francois, J., Palamarczyk, G., 2010. The isoprenoid pathway and 
transcriptional response to its inhibitors in the yeast Saccharomyces 
cerevisiae. FEMS yeast research. 10, 14-27. 
Liu, J., Zhang, W., Du, G., Chen, J., Zhou, J., 2013. Overproduction of geraniol by 
enhanced precursor supply in Saccharomyces cerevisiae. Journal of 
biotechnology. 168, 446-51. 
Liu, W., Xu, X., Zhang, R., Cheng, T., Cao, Y., Li, X., Guo, J., Liu, H., Xian, M., 2016. 
Engineering Escherichia coli for high-yield geraniol production with 
biotransformation of geranyl acetate to geraniol under fed-batch culture. 
Biotechnology for biofuels. 9, 58. 
Livak, K. J., Schmittgen, T. D., 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25, 
402-8. 
Mateus, C., Avery, S., 2000. Destabilized green fluorescent protein for monitoring 
dynamic changes in yeast gene expression with flow cytometry. Yeast 
(Chichester, England). 16, 1313 - 1323. 
Meadows, A. L., Hawkins, K. M., Tsegaye, Y., Antipov, E., Kim, Y., Raetz, L., Dahl, R. 
H., Tai, A., Mahatdejkul-Meadows, T., Xu, L., Zhao, L., Dasika, M. S., 
Murarka, A., Lenihan, J., Eng, D., Leng, J. S., Liu, C. L., Wenger, J. W., Jiang, 
H., Chao, L., Westfall, P., Lai, J., Ganesan, S., Jackson, P., Mans, R., Platt, 
D., Reeves, C. D., Saija, P. R., Wichmann, G., Holmes, V. F., Benjamin, K., 
Hill, P. W., Gardner, T. S., Tsong, A. E., 2016. Rewriting yeast central carbon 
metabolism for industrial isoprenoid production. Nature. 537, 694-697. 
Nielsen, L. K., 2011. Metabolic engineering: from retrofitting to green field. Nature 
chemical biology. 7, 408-9. 
Paddon, C. J., Westfall, P. J., Pitera, D. J., Benjamin, K., Fisher, K., McPhee, D., 
Leavell, M. D., Tai, A., Main, A., Eng, D., Polichuk, D. R., Teoh, K. H., Reed, 
D. W., Treynor, T., Lenihan, J., Fleck, M., Bajad, S., Dang, G., Dengrove, D., 
Diola, D., Dorin, G., Ellens, K. W., Fickes, S., Galazzo, J., Gaucher, S. P., 
Geistlinger, T., Henry, R., Hepp, M., Horning, T., Iqbal, T., Jiang, H., Kizer, L., 
Lieu, B., Melis, D., Moss, N., Regentin, R., Secrest, S., Tsuruta, H., Vazquez, 
R., Westblade, L. F., Xu, L., Yu, M., Zhang, Y., Zhao, L., Lievense, J., Covello, 
P. S., Keasling, J. D., Reiling, K. K., Renninger, N. S., Newman, J. D., 2013. 
High-level semi-synthetic production of the potent antimalarial artemisinin. 
Nature. 496, 528-32. 
Paltauf, F., Kohlwein, S. D., Henry, S. A., 1992. 8 Regulation and 
Compartmentalization of Lipid Synthesis in Yeast. Cold Spring Harbor 
Monograph Archive. 21, 415-500. 
Parks, L. W., Smith, S. J., Crowley, J. H., 1995. Biochemical and physiological 
effects of sterol alterations in yeast--a review. Lipids. 30, 227-30. 
Peng, B., Plan, M. R., Carpenter, A., Nielsen, L. K., Vickers, C. E., 2017a. Coupling 
gene regulatory patterns to bioprocess conditions to optimize synthetic 
metabolic modules for improved sesquiterpene production in yeast. 
Biotechnology for biofuels. 10, 43. 
Peng, B., Plan, M. R., Chrysanthopoulos, P., Hodson, M. P., Nielsen, L. K., Vickers, 
C. E., 2017b. A squalene synthase protein degradation method for improved 
sesquiterpene production in Saccharomyces cerevisiae. Metabolic 
engineering. 39, 209–219. 
25 
 
Peng, B., Williams, T., Henry, M., Nielsen, L., Vickers, C., 2015. Controlling 
heterologous gene expression in yeast cell factories on different carbon 
substrates and across the diauxic shift: a comparison of yeast promoter 
activities. Microbial cell factories. 14, 91. 
Poulter, C. D., Rilling, H. C., 1976. Prenyltransferase: the mechanism of the reaction. 
Biochemistry. 15, 1079-83. 
Rico, J., Pardo, E., Orejas, M., 2010. Enhanced production of a plant monoterpene 
by overexpression of the 3-hydroxy-3-methylglutaryl coenzyme A reductase 
catalytic domain in Saccharomyces cerevisiae. Applied and environmental 
microbiology. 76, 6449-54. 
Sabri, S., Steen, J. A., Bongers, M., Nielsen, L. K., Vickers, C. E., 2013. Knock-
in/Knock-out (KIKO) vectors for rapid integration of large DNA sequences, 
including whole metabolic pathways, onto the Escherichia coli chromosome at 
well-characterised loci. Microbial cell factories. 12, 60. 
Saito, A., Rilling, H. C., 1979. Prenyltransferase. Product binding and reaction 
termination. The Journal of biological chemistry. 254, 8511-5. 
Sarria, S., Wong, B., Martin, H. G., Keasling, J. D., Peralta-Yahya, P., 2014. 
Microbial Synthesis of Pinene. ACS synthetic biology. 
Scalcinati, G., Knuf, C., Partow, S., Chen, Y., Maury, J., Schalk, M., Daviet, L., 
Nielsen, J., Siewers, V., 2012. Dynamic control of gene expression in 
Saccharomyces cerevisiae engineered for the production of plant 
sesquitepene alpha-santalene in a fed-batch mode. Metabolic engineering. 14, 
91-103. 
Servouse, M., Karst, F., 1986. Regulation of early enzymes of ergosterol 
biosynthesis in Saccharomyces cerevisiae. The Biochemical journal. 240, 
541-7. 
Sonderegger, M., Jeppsson, M., Hahn-Hagerdal, B., Sauer, U., 2004. Molecular 
basis for anaerobic growth of Saccharomyces cerevisiae on xylose, 
investigated by global gene expression and metabolic flux analysis. Applied 
and environmental microbiology. 70, 2307-17. 
Stephanopoulos, G., Vallino, J. J., 1991. Network rigidity and metabolic engineering 
in metabolite overproduction. Science. 252, 1675-81. 
Suzuki, T., Varshavsky, A., 1999. Degradation signals in the lysine-asparagine 
sequence space. The EMBO journal. 18, 6017-26. 
Taxis, C., Stier, G., Spadaccini, R., Knop, M., 2009. Efficient protein depletion by 
genetically controlled deprotection of a dormant N-degron. Molecular systems 
biology. 5, 267. 
Tokuhiro, K., Muramatsu, M., Ohto, C., Kawaguchi, T., Obata, S., Muramoto, N., 
Hirai, M., Takahashi, H., Kondo, A., Sakuradani, E., Shimizu, S., 2009. 
Overproduction of geranylgeraniol by metabolically engineered 
Saccharomyces cerevisiae. Applied and environmental microbiology. 75, 
5536-43. 
Vickers, C. E., Behrendorff, J. B., Bongers, M., Brennan, T. C., Bruschi, M., Nielsen, 
L. K., 2015a. Production of Industrially Relevant Isoprenoid Compounds in 
Engineered Microbes. Microorganisms in Biorefineries. Springer, pp. 303-334. 
Vickers, C. E., Bongers, M., Bydder, S. F., Chrysanthopoulos, P., Hodson, M. P., 
2015b. Protocols for the production and analysis of isoprenoids in bacteria 
and yeast. Springer Protocols Handbooks. Springer, pp. 1-30. 
Vickers, C. E., Bongers, M., Liu, Q., Delatte, T., Bouwmeester, H., 2014. Metabolic 
engineering of volatile isoprenoids in plants and microbes. Plant, cell & 
environment. 37, 1753-75. 
Vickers, C. E., Williams, T. C., Peng, B., Cherry, J., 2017. Recent advances in 
synthetic biology for engineering isoprenoid production in yeast. Current 
opinion in chemical biology. 40, 47-56. 
26 
 
Vik, A., Rine, J., 2001. Upc2p and Ecm22p, dual regulators of sterol biosynthesis in 
Saccharomyces cerevisiae. Molecular and cellular biology. 21, 6395-6405. 
Willrodt, C., David, C., Cornelissen, S., Buhler, B., Julsing, M. K., Schmid, A., 2014. 
Engineering the productivity of recombinant Escherichia coli for limonene 
formation from glycerol in minimal media. Biotechnology journal. 9, 1000-12. 
Xie, W., Ye, L., Lv, X., Xu, H., Yu, H., 2014. Sequential control of biosynthetic 
pathways for balanced utilization of metabolic intermediates in 
Saccharomyces cerevisiae. Metabolic engineering. 28C, 8-18. 
Yang, H., Tong, J., Lee, C. W., Ha, S., Eom, S. H., Im, Y. J., 2015. Structural 
mechanism of ergosterol regulation by fungal sterol transcription factor Upc2. 
Nature communications. 6, 6129. 
Zebec, Z., Wilkes, J., Jervis, A. J., Scrutton, N. S., Takano, E., Breitling, R., 2016. 
Towards synthesis of monoterpenes and derivatives using synthetic biology. 
Current opinion in chemical biology. 34, 37-43. 
Zhang, H., Liu, Q., Cao, Y., Feng, X., Zheng, Y., Zou, H., Liu, H., Yang, J., Xian, M., 
2014. Microbial production of sabinene--a new terpene-based precursor of 
advanced biofuel. Microb Cell Fact. 13, 20. 
Zhao, J., Bao, X., Li, C., Shen, Y., Hou, J., 2016. Improving monoterpene geraniol 
production through geranyl diphosphate synthesis regulation in 
Saccharomyces cerevisiae. Applied microbiology and biotechnology. 100, 
4561-4571. 
Zhao, J., Li, C., Zhang, Y., Shen, Y., Hou, J., Bao, X., 2017. Dynamic control of 
ERG20 expression combined with minimized endogenous downstream 
metabolism contributes to the improvement of geraniol production in 
Saccharomyces cerevisiae. Microbial cell factories. 16, 17. 
Zhuang, X., Engineering novel terpene production platforms in the yeasts 
Saccharomyces cerevisiae. Plant Physiology, Vol. PhD. University of 
Kentucky, 2013. 
 
Highlights 
 Farnesyl pyrophosphate synthase (Erg20p) consumes the monoterpene precursor 
geranyl pyrophosphate 
 N-degron mediated protein degradation and sterol responsive promoters were applied 
to regulate ERG20/Erg20p 
 The mevalonate pathway was combinatorially enhanced to facilitate precursor 
synthesis 
 Destabilization of Erg20p effectively improved the production of monoterpenes 
 In the final engineered strains, 18 mg L-1 linalool or 76 mg L-1 limonene were 
produced 
 
